Mental Disorders clinical trials

Explore recruiting mental disorders clinical trials.

Recruiting mental disorders studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mental Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of psilocybin on the positive valence system in treatment-resistant depression: a pilot clinical neuroimaging study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial

Norway

Phase III and phase IV (Integrated) EU CTIS Study details

A study to investigate the safety, pharmacodynamics and pharmacokinetics of increasing doses of subcutaneously administered deuterated DMT (CYB004) in healthy subjects

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

RESET-TRD; a Randomised trial on oral ESketamine compared to Electroconvulsive Therapy for patients with Treatment Resistant Depression

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mental Disorders trials by city

Mental Disorders in Toronto Mental Disorders in Vancouver Mental Disorders in Montreal Mental Disorders in Calgary Mental Disorders in Edmonton Mental Disorders in Ottawa Mental Disorders in Winnipeg Mental Disorders in Quebec City Mental Disorders in Hamilton Mental Disorders in Kitchener Mental Disorders in London Mental Disorders in Halifax Mental Disorders in New York Mental Disorders in Los Angeles Mental Disorders in Chicago Mental Disorders in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease